INSIGHT & ANALYSIS

Our Recent Publications Include:

SEC Proposes Amendments to Further Modernize Regulation S-K Disclosure Requirements

First FSVP Warning Letter Issued by the FDA

CMS Makes CAR T-Cell Cancer Therapy Available to Medicare Beneficiaries Nationwide

IRS Issues Proposed Regulations Classifying Cloud Transactions and Transfers of Digital Content for U.S. Federal Income Tax Purposes

Delaware Court of Chancery Addresses Significant Issues Regarding Private Company Deal Litigation

Sitting Here on Capitol Hill: Congressional Developments on Life Science and Consumer Product Issues - August 13, 2019

The Entrepreneurs Report: Private Company Financing Trends - 1H 2019

CMS Releases Key 2020 Payment and Policy Proposals

FDA Suspends Facility Registration of Texas-Based Seafood Producer

FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues

Website Operator Jointly Liable for Data Collection and Transmission Through Facebook "Like" Button

Retaining Ephemeral Messages To Prepare For DOJ Scrutiny

Sitting Here on Capitol Hill: Congressional Developments on Life Science and Consumer Product Issues - July 26, 2019

Modernizing EU Competition Policy: Will the EU's Angst with Chinese State-Owned Companies Help U.S. Tech Firms off the European Commission's Hook?

FTC Settles Data Security Case, Continuing Trend of Requiring Comprehensive Security Programs and Third-Party Assessments

Second Circuit Affirms That President Trump Cannot Block Critics on Twitter

President Trump Issues Executive Order on Advancing Kidney Health

DOJ's Antitrust Division Announces New Policy Incentivizing Qualified Corporate Antitrust Compliance Programs

FDA Prioritizes Review Generic Drug Products to Treat Opioid Overdose

Sitting Here on Capitol Hill: Congressional Developments on Life Science and Consumer Product Issues - July 2019

2019 Diversity Newsletter

After Three-Year Wait, Court Allows First Amendment Challenge to Copyright Law to Proceed

Companies with New Cancer Drug Candidates Should Plan Now for August 2020

Another Shot Across the Bows: EC Levies $32 Million Gun-Jumping Fine on Canon

The ICO Publishes Its Stance on Adtech and Real-Time Bidding

Delaware Court of Chancery Allows Claims Against a Board, Financial Advisor, and Acquiror in a Company Sale

FDA Updates Paragraph IV Certification List to Help Spur Investment in Generic Drug Development

FDA Target of Executive Order on Agricultural Biotechnology

Long-Awaited Development Fee Cases Released

Digital Health Report - Summer 2019

Delaware Supreme Court Provides Guidance on Board Oversight Obligations

 

Search by:
Publications:
Practice Area:
Publish Date:
    

 

On-Demand Learning


Related Information


WSGR Subscription Center